Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
BMC Gastroenterol ; 20(1): 212, 2020 Jul 08.
Artículo en Inglés | MEDLINE | ID: mdl-32640995

RESUMEN

BACKGROUND: To evaluate an innovative open necrosectomy strategy with continuous positive drainage and prophylactic diverting loop ileostomy for the management of late infected pancreatic necrosis (LIPN). METHODS: Consecutive patients were divided into open necrosectomy (ON) group (n = 23), open necrosectomy with colonic segment resection (ON+CSR) group (n = 8) and open necrosectomy with prophylactic diverting loop ileostomy (ON+PDLI) group (n = 11). Continuous positive drainage (CPD) via double-lumen irrigation-suction tube (DLIST) was performed in ON+PDLI group. The primary endpoints were duration of organ failure after surgery, postoperative complication, the rate of re-surgery and mortality. The secondary endpoints were duration of hospitalization, cost, time interval between open surgery and total enteral nutrition (TEN). RESULTS: The recovery time of organ function in ON+PDLI group was shorter than that in other two groups. Colonic complications occurred in 13 patients (56.5%) in the ON group and 3 patients (27.3%) in the ON+PDLI group (p = 0.11). The length of stay in the ON+PDLI group was shorter than the ON group (p = 0.001). The hospitalization cost in the ON+PDLI group was less than the ON group (p = 0.0052). CONCLUSION: ON+PDLI can avoid the intestinal dysfunction, re-ileostomy, the resection of innocent colon and reduce the intraoperative trauma. Despite being of colonic complications before or during operation, CPD + PDLI may show superior effectiveness, safety, and convenience in LIPN.


Asunto(s)
Infecciones Intraabdominales , Pancreatitis Aguda Necrotizante , Drenaje , Humanos , Ileostomía/efectos adversos , Pancreatitis Aguda Necrotizante/cirugía , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/prevención & control , Estudios Retrospectivos , Resultado del Tratamiento
2.
Inflamm Res ; 62(4): 407-15, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23340865

RESUMEN

BACKGROUND: Gut barrier failure caused by endotoxemia is a life-threatening problem. The present study aimed to determine whether any specific intestinal site is highly correlated with gut barrier failure, and whether recombinant human growth hormone (rhGH) can ameliorate gut barrier failure in a rat model of endotoxemia. METHODS: Enterostomy tubes were surgically placed in adult male Sprague-Dawley rats three days before induction of endotoxemia by lipopolysaccharide (LPS) injection. Controls received no LPS. Rats were then randomly assigned to receive subcutaneous injections of rhGH (experimental, n = 30) or 0.9 % saline (control, n = 15) at 24, 48, or 72 h after LPS injection. Escherichia coli labeled with green fluorescent protein (GFP) were injected into the intestinal segment of all rats through the enterostomy tubes. The number of GFP-labeled E. coli detected in mesenteric lymph nodes was examined after 96 h. Apoptosis and proliferation rates of intestinal epithelial cells, and intestinal permeability were measured. RESULTS: Endotoxemia led to high mortality, compared with the control group, and rhGH treatment did not improve survival. Intestinal permeability, reflected by translocation rates of GFP-labeled E. coli, and apoptosis rates in the LPS-induced endotoxemia group were higher than those in the non-endotoxemia control group, and the endotoxemia ileum group had the highest rates of both bacterial translocation and apoptosis. The LPS+GH group had less bacterial translocation and apoptosis than the LPS-induced endotoxemia group. In contrast, the proliferation rates were lower in the LPS group compared to the LPS+GH group. CONCLUSIONS: Endotoxemia can induce gut barrier failure in rats, and the ileum is the site of greatest risk. The GH can reduce the incidence of endotoxemia-induced gut barrier failure, but not the associated mortality.


Asunto(s)
Endotoxemia/tratamiento farmacológico , Infecciones por Escherichia coli/tratamiento farmacológico , Hormona de Crecimiento Humana/uso terapéutico , Intestinos/efectos de los fármacos , Animales , Apoptosis , Traslocación Bacteriana , Endotoxemia/metabolismo , Endotoxemia/microbiología , Endotoxemia/patología , Escherichia coli/fisiología , Infecciones por Escherichia coli/metabolismo , Infecciones por Escherichia coli/microbiología , Infecciones por Escherichia coli/patología , Hormona de Crecimiento Humana/farmacología , Mucosa Intestinal/metabolismo , Intestinos/microbiología , Intestinos/patología , Lipopolisacáridos , Ganglios Linfáticos/microbiología , Masculino , Permeabilidad/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes/farmacología , Proteínas Recombinantes/uso terapéutico
3.
Surg Laparosc Endosc Percutan Tech ; 30(3): 227-232, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31977971

RESUMEN

To establish a continuous reinfusion of succus entericus and enteral nutrition (EN) in complex high-output fistula (HOF). Percutaneous puncture and catheterization technique was used to establish continuous reinfusion of succus entericus and EN in complex HOF. From May 2010 to June 2018, 21 patients with complex HOF used continuous reinfusion of succus entericus and EN. Six of them were completely cured, and 15 cases were cured after definitive surgery. Percutaneous puncture and catheterization technique was shown to be a useful and effective method for establishing continuous reinfusion of succus entericus and EN in patients with complex HOF. This method can prevent succus entericus loss and remove the barrier to implementing EN in HOF.


Asunto(s)
Colostomía , Nutrición Enteral/métodos , Fístula Intestinal/terapia , Secreciones Intestinales , Adulto , Femenino , Humanos , Fístula Intestinal/diagnóstico por imagen , Fístula Intestinal/etiología , Masculino , Persona de Mediana Edad , Nutrición Parenteral , Estudios Retrospectivos
4.
Am Surg ; 85(4): 376-383, 2019 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-31043198

RESUMEN

This study aimed to assess the efficacy of double-lumen irrigation-suction tube (DLIST) in treating severe intra-abdominal infection (SIAI) induced by endoscopic sphincterotomy-related perforation (EST-rP). We enrolled 34 consecutive patients who had been transferred to our hospital with SIAI induced by EST-rP from January 2000 to June 2018. Then they were assigned into two groups based on whether or not rescue surgery had been performed: failed nonoperative treatment group (n = 9) and failed rescue surgery treatment group (n = 25). All 34 patients received DLIST for positive draining by surgery in our hospital. Data collection included demographics, indication for endoscopic retrograde cholangiopancreatography, time to rescue surgery, surgical procedure, surgical success rate, complications, hospital stay, and postoperative outcome. The research enrolled 34 patients (ages 27-79 years, mean of 57.8 ± 12.1 years). There were no significant differences in age and gender between two groups (P > 0.05). After being admitted, they were diagnosed with sepsis induced by SIAI (Sequential Organ Failure Assessment score range of 2-6, mean of 3.6 ± 0.95). The time from endoscopic retrograde cholangiopancreatography to rescue surgery was 12 to 336 hours (mean of 73.7 ± 72.2 hours); overall hospital stay was 15 to 405 (mean of 127.5 ± 81.5) days. The hospital stay was significantly longer in the failed rescue surgery group than that of the failed nonoperative treatment group (P < 0.05). The overall mortality rate was 11.8 per cent (4/34). The mortality rate was 16 per cent (4/25) and 0 per cent (0/9), respectively. As a modified suction technology, DLIST placement can effectively treat SIAI induced by EST-rP and lower the mortality rate of rescue surgery treatment.


Asunto(s)
Infecciones Intraabdominales/terapia , Complicaciones Posoperatorias/terapia , Esfinterotomía Endoscópica/efectos adversos , Succión/instrumentación , Adulto , Anciano , Colangiopancreatografia Retrógrada Endoscópica , Femenino , Humanos , Infecciones Intraabdominales/etiología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Succión/métodos , Resultado del Tratamiento
5.
J Laparoendosc Adv Surg Tech A ; 29(7): 905-908, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-30874460

RESUMEN

Background: Coupled plasma filtration adsorption (CPFA) is an extracorporeal treatment based on plasma filtration associated with an adsorbent cartridge and hemofiltration. CPFA is able to remove inflammatory mediators and it has been used to treat severe sepsis and multiple organ dysfunction. Limited experience exists on the use of CPFA in treating intra-abdominal infection (IAI). Methods: In this study, the efficacy of CPFA in treating patients with severe IAI and liver failure was evaluated in a retrospective analysis of 76 cases. Results: The survival rate of patients treated with CPFA was 82.6%, with effective removal of endotoxin and inflammatory mediators. Conclusion: Our data suggest that CPFA can be safely and effectively used to lower morbidity and mortality rates of patients with severe IAI and liver failure.


Asunto(s)
Endotoxinas/química , Hemofiltración , Infecciones Intraabdominales/terapia , Plasma , Adsorción , Adulto , Anciano , Femenino , Humanos , Infecciones Intraabdominales/complicaciones , Fallo Hepático/complicaciones , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Tasa de Supervivencia
6.
Medicine (Baltimore) ; 98(10): e14653, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30855454

RESUMEN

RATIONALE: Currently, fistucolysis helps to establish intestinal nutrition and succus entericus reinfusion in the case of controllable mature high-output enterocutaneous fistula. However, if the tube cannot reach the distal limb of a fistula, fistuloclysis is not achieved. We proposed a strategy to establish succus entericus reinfusion for intractable intestinal fistula through percutaneous enterostomy. PATIENT CONCERNS: A 43-year-old man was transferred to our facility for postoperative enterocutaneous fistulae, sepsis, malnutrition, and electrolyte and fluid imbalance. The contrast X-ray demonstrated the breakdown of the primary anastomosis, with fistula output ranging from 1500 to 2000 mL/d, despite the administration of medications to reduce gastrointestinal secretions. DIAGNOSES: The patient was diagnosed with high-output anastomosis fistula by gastrointestinal radiography. INTERVENTIONS: We used percutaneous enterostomy to establish fistuloclysis. OUTCOMES: Fistuloclysis was established by percutaneous enterostomy successfully. No complications were found during the past 4-month follow-up after percutaneous enterostomy. He is waiting for reconstruction surgery after 6 months' enteral nutrition (EN). LESSONS: Fistuloclysis-assisted EN, if used appropriately, avoids the complications of long-term parenteral nutrition (PN) and may promote faster fistula healing.


Asunto(s)
Nutrición Enteral/métodos , Enterostomía/métodos , Fluidoterapia/métodos , Fístula Intestinal , Complicaciones Posoperatorias/terapia , Sepsis , Desequilibrio Hidroelectrolítico , Adulto , Humanos , Fístula Intestinal/diagnóstico , Fístula Intestinal/etiología , Fístula Intestinal/fisiopatología , Fístula Intestinal/cirugía , Intestinos/diagnóstico por imagen , Intestinos/fisiopatología , Masculino , Estado Nutricional , Radiografía Abdominal/métodos , Sepsis/etiología , Sepsis/terapia , Estomas Quirúrgicos , Resultado del Tratamiento , Desequilibrio Hidroelectrolítico/etiología , Desequilibrio Hidroelectrolítico/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA